Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris Guiu

Showing results (231-240 of 241) with videos related to

Pageof 25
Sort By:
The Lancet. Gastroenterology & Hepatology|November 9, 2020
Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trialEtienne Garin, Lambros Tselikas, Boris Guiu, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 24, 2022
FFCD 1709-SIRTCI phase II trial: Selective internal radiation therapy plus Xelox, Bevacizumab and Atezolizumab in liver-dominant metastatic colorectal cancerViolaine Randrian, Simon Pernot, Karine Le Malicot, et al.
Gut|May 19, 2019
Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumabAnthony Dohan, Benoit Gallix, Boris Guiu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 25, 2022
Defining textbook outcome for selective internal radiation therapy of hepatocellular carcinoma: an international expert studyJules Gregory, Lambros Tselikas, Caroline Allimant, et al.
Hepatology (Baltimore, Md.)|April 8, 2026
Neoadjuvant and adjuvant nivolumab associated with irreversible electroporation in patients with BCLC a hepatocellular carcinoma and high risk of recurrence (NIVOLEP trial)Pierre Nahon, Marianne Ziol, Long Pan, et al.
European Journal of Cancer (Oxford, England : 1990)|March 17, 2024
Biliary tract cancers: French national clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, AFEF, SFRO, SFP, SFR, ACABi, ACHBPT)Gael S Roth, Loic Verlingue, Matthieu Sarabi, et al.
The Lancet. Oncology|November 7, 2017
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trialValérie Vilgrain, Helena Pereira, Eric Assenat, et al.
The Lancet. Gastroenterology & Hepatology|February 23, 2025
[<sup>18</sup>F]fluorodeoxyglucose and [<sup>18</sup>F]fluorocholine PET-CT for staging optimisation and treatment modification in hepatocellular carcinoma (PET-HCC01): a prospective multicentre studyJean-Charles Nault, Marouane Boubaya, Myriam Wartski, et al.
European Radiology|June 6, 2020
Correction to: National dose reference levels in computed tomography-guided interventional procedures-a proposalJoël Greffier, Gilbert Ferretti, Julia Rousseau, et al.
European Radiology|May 4, 2020
National dose reference levels in computed tomography-guided interventional procedures-a proposalJoël Greffier, Gilbert Ferretti, Julia Rousseau, et al.
Pageof 25

Showing results (231-240 of 241) with videos related to

Sort By:
Pageof 25
The Lancet. Gastroenterology & Hepatology|November 9, 2020
Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trialEtienne Garin, Lambros Tselikas, Boris Guiu, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 24, 2022
FFCD 1709-SIRTCI phase II trial: Selective internal radiation therapy plus Xelox, Bevacizumab and Atezolizumab in liver-dominant metastatic colorectal cancerViolaine Randrian, Simon Pernot, Karine Le Malicot, et al.
Gut|May 19, 2019
Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumabAnthony Dohan, Benoit Gallix, Boris Guiu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 25, 2022
Defining textbook outcome for selective internal radiation therapy of hepatocellular carcinoma: an international expert studyJules Gregory, Lambros Tselikas, Caroline Allimant, et al.
Hepatology (Baltimore, Md.)|April 8, 2026
Neoadjuvant and adjuvant nivolumab associated with irreversible electroporation in patients with BCLC a hepatocellular carcinoma and high risk of recurrence (NIVOLEP trial)Pierre Nahon, Marianne Ziol, Long Pan, et al.
European Journal of Cancer (Oxford, England : 1990)|March 17, 2024
Biliary tract cancers: French national clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, AFEF, SFRO, SFP, SFR, ACABi, ACHBPT)Gael S Roth, Loic Verlingue, Matthieu Sarabi, et al.
The Lancet. Oncology|November 7, 2017
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trialValérie Vilgrain, Helena Pereira, Eric Assenat, et al.
The Lancet. Gastroenterology & Hepatology|February 23, 2025
[<sup>18</sup>F]fluorodeoxyglucose and [<sup>18</sup>F]fluorocholine PET-CT for staging optimisation and treatment modification in hepatocellular carcinoma (PET-HCC01): a prospective multicentre studyJean-Charles Nault, Marouane Boubaya, Myriam Wartski, et al.
European Radiology|June 6, 2020
Correction to: National dose reference levels in computed tomography-guided interventional procedures-a proposalJoël Greffier, Gilbert Ferretti, Julia Rousseau, et al.
European Radiology|May 4, 2020
National dose reference levels in computed tomography-guided interventional procedures-a proposalJoël Greffier, Gilbert Ferretti, Julia Rousseau, et al.
Pageof 25